Open Access Research Article

LH Priming Before Ovarian Stimulation in Poor Responders: Effects on Oocyte Recovery and Post ICSI/IVF Pregnancy Rates

Mario Mignini Renzini1, Claudio Brigante1, Silvana Gippone1, Letizia Brienza1, Diana Turchi1, Elena De Ponti2, Mariabeatrice Dal Canto1 and Jose Buratini1,3*

1Biogenesi, Reproductive Medicine Centre, Istituti Clinici Zucchi, Monza, Italy

2Department of Medical Physics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy

3Department of Structural and Functional Biology, Institute of Biosciences, Sao Paulo State University, Botucatu, Brazil

Corresponding Author

Received Date: May 17, 2024;  Published Date: June 13, 2024

Abstract

Background: Androgen-mediated LH activity stimulates early follicle growth. LH pre- treatment appears to improve ovarian responses in ICSI/ IVF practice but has not yet been sufficiently assessed in poor responders.

Methods: POSEIDON-4 patients (maternal age≥35; AFC<5 and/or AMH <1.2ng/mL) were stimulated with FSH+LH in a flexible antagonist protocol (Control; n=129) or subjected to the same stimulatory treatment preceded by a seven-day LH priming (150 IU/day) under GnRHa downregulation (LH priming; n=106). Follicular responses and ICSI/IVF outcomes were compared between treatment-groups in overall patients and in a subgroup of 136 patients with severely decreased follicular availability (AMH<0.75ng/mL).

Results: Overall POSEIDON-4 patients in the “LH priming” group achieved a twice higher clinical pregnancy rate (p=0.02), accompanied by a 40% reduction in cycle cancellation (p=0.03) and increased production of viable embryos (p=0.02). A multivariate analysis indicated a robust association between “LH priming” and pregnancy achievement, independent of confounding variables (OR=2.58; p=0.02). A two-fold increase in clinical pregnancy rate was also observed in severely restricted POSEIDON-4 patients in the “LH priming” group (p=0.05), this time, accompanied by a higher oocyte yield (p≤0.04).

Conclusion: A pre-ovarian stimulation LH priming can markedly improve ICSI/IVF outcomes of POSEIDON-4 patients, benefiting in different ways subgroups of this challenging patient group.

Keywords: Luteinizing hormone; Ovarian stimulation; Oocyte; ICSI; IVF; Poor responders; Advanced maternal age

Citation
Signup for Newsletter
Scroll to Top